Evidence map›Paper›PMID 29326686›Full record

ArticleFrontiers in immunology2017

Regulation of Fn14 Receptor and NF-κB Underlies Inflammation in Meniere's Disease.

Lidia Frejo, Teresa Requena, Satoshi Okawa, Alvaro Gallego-Martinez, Manuel Martinez-Bueno, Ismael Aran, Angel Batuecas-Caletrio, Jesus Benitez-Rosario, Juan M Espinosa-Sanchez, Jesus José Fraile-Rodrigo and 14 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 4 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 4 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. A Systematic Review on the Role of the Stria Vascularis in Menière's Disease Pathogenesis.Journal of the Association for Research in Otolaryngology : JARO · 2025
    Pooled it
  3. Systemic pharmacological interventions for Ménière's disease.The Cochrane database of systematic reviews · 2023
    Pooled it
  4. Pooled it
  5. Article
  6. ZDHHC5 may regulate the function of NKT cells and the immune response in Meniere's disease.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Article
  7. Review
  8. Review
  9. Article
  10. Changes in the Neurovascular Unit in Meniere's Disease.Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2025
    Article
  11. Whole genome DNA methylation profiles define Meniere's disease subclusters.Journal of molecular medicine (Berlin, Germany) · 2025
    Article
  12. Article
  13. Immunological mechanisms in Meniere's disease.Frontiers in immunology · 2025
    Review
  14. Article
  15. Review
  16. Article
  17. Redox Modulation of Meniere Disease byCurrent neuropharmacology · 2024
    Article
  18. Article
  19. Genetic advances in Meniere Disease.Molecular biology reports · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 16 institutions in 4 countries.

Lidia FrejoOtology and Neurotology Group CTS495, Department of Genomic Medicine - Centre for Genomics and Oncological Research - Pfizer/Universidad de Granada/Junta de Andalucía (GENYO), Granada, Spain.
Teresa RequenaOtology and Neurotology Group CTS495, Department of Genomic Medicine - Centre for Genomics and Oncological Research - Pfizer/Universidad de Granada/Junta de Andalucía (GENYO), Granada, Spain.
Satoshi OkawaComputational Biology Group, Luxembourg Centre for Systems Biomedicine (LCSB), Universite du Luxembourg, Belval, Luxembourg.
Alvaro Gallego-MartinezOtology and Neurotology Group CTS495, Department of Genomic Medicine - Centre for Genomics and Oncological Research - Pfizer/Universidad de Granada/Junta de Andalucía (GENYO), Granada, Spain.
Manuel Martinez-BuenoGroup of Genetics of Complex Diseases, Department of Genomic Medicine - Centre for Genomics and Oncological Research - Pfizer/Universidad de Granada/Junta de Andalucía (GENYO), Granada, Spain.
Ismael AranDepartment of Otolaryngology, Complexo Hospitalario de Pontevedra, Pontevedra, Spain.
Angel Batuecas-CaletrioDepartment of Otolaryngology, Hospital Universitario Salamanca, IBSAL, Salamanca, Spain.
Jesus Benitez-RosarioDepartment of Otolaryngology, Hospital Universitario de Gran Canaria Dr Negrin, Las Palmas de Gran Canaria, Las Palmas, Spain.
Juan M Espinosa-SanchezOtology and Neurotology Group CTS495, Department of Genomic Medicine - Centre for Genomics and Oncological Research - Pfizer/Universidad de Granada/Junta de Andalucía (GENYO), Granada, Spain.
Jesus José Fraile-RodrigoDepartment of Otolaryngology, Hospital Miguel Servet, Zaragoza, Spain.
Ana María García-ArumiDepartment of Otorhinolaryngology, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
Rocío González-AguadoDepartment of Otorhinolaryngology, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain.
Pedro MarquesDepartment of Otorhinolaryngology, Centro Hospitalar de S.João, EPE, University of Porto Medical School, Porto, Portugal.
Eduardo Martin-SanzDepartment of Otolaryngology, Hospital Universitario de Getafe, Getafe, Madrid, Spain.
Nicolas Perez-FernandezDepartment of Otolaryngology, Clínica Universidad de Navarra, Pamplona, Spain.
Paz Pérez-VázquezDepartment of Otorhinolaryngology, Hospital Universitario de Cabueñes, Gijón, Asturias, Spain.
Herminio Perez-GarriguesDepartment of Otorhinolaryngology, Hospital La Fe, Valencia, Spain.
Sofía Santos-PerezDivision of Otoneurology, Department of Otorhinolaryngology, Complexo Hospitalario Universitario, Santiago de Compostela, Spain.
Andres Soto-VarelaDivision of Otoneurology, Department of Otorhinolaryngology, Complexo Hospitalario Universitario, Santiago de Compostela, Spain.
Maria C TapiaDepartment of Otorhinolaryngology, Instituto Antolí Candela, Madrid, Spain.
Gabriel Trinidad-RuizDivision of Otoneurology, Department of Otorhinolaryngology, Complejo Hospitalario Badajoz, Badajoz, Spain.
Antonio Del SolComputational Biology Group, Luxembourg Centre for Systems Biomedicine (LCSB), Universite du Luxembourg, Belval, Luxembourg.
Marta E Alarcon RiquelmeGroup of Genetics of Complex Diseases, Department of Genomic Medicine - Centre for Genomics and Oncological Research - Pfizer/Universidad de Granada/Junta de Andalucía (GENYO), Granada, Spain.
Jose A Lopez-EscamezOtology and Neurotology Group CTS495, Department of Genomic Medicine - Centre for Genomics and Oncological Research - Pfizer/Universidad de Granada/Junta de Andalucía (GENYO), Granada, Spain.
Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research · ESUniversity of Luxembourg · LUCentro de Implantología Cirugía Oral y Maxilofacial · ESClinica Universidad de Navarra · ESComplejo Hospitalario de Pontevedra · ESComplejo Hospitalario Universitario de Santiago · ESComplexo Hospitalario Universitario A Coruña · ESHospital Universitario De Cabueñes · ESHospital Universitario de Getafe · ESHospital Universitario de Gran Canaria Doctor Negrín · ESHospital Universitario Miguel Servet · ESHospital Universitario Virgen de las Nieves · ESInstituto de Investigación Biomédica de Salamanca · ESMarqués de Valdecilla University Hospital · ESUniversidade do Porto · PTVall d'Hebron Hospital Universitari · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Meniere's disease (MD) is a rare disorder characterized by episodic vertigo, sensorineural hearing loss, tinnitus, and aural fullness. It is associated with a fluid imbalance between the secretion of endolymph in the cochlear duct and its reabsorption into the subarachnoid space, leading to an accumulation of endolymph in the inner ear. Epidemiological evidence, including familial aggregation, indicates a genetic contribution and a consistent association with autoimmune diseases (AD). We conducted a case-control study in two phases using an immune genotyping array in a total of 420 patients with bilateral MD and 1,630 controls. We have identified the first locus, at 6p21.33, suggesting an association with bilateral MD [meta-analysis leading signal rs4947296, OR = 2.089 (1.661-2.627);

Indexed as

Meniere’s diseaseNFKB1NF-κB signalingsensorineural hearing lossTNFRSF12ATWEAK/Fn14 pathwayvertigo

Identifiers

PMID29326686
PMCPMC5733484
OpenAlexW2775697776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.